In addition to oral administration, Spritam may now be administered via nasogastric tube (NG tube) or gastrostomy tube (G tube). The approval was based on data confirming that the drug can be ...

The Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted 10-1 against the approval of brexpiprazole in combination with sertraline for the treatment of adults ...

Vusolimogene oderparepvec is a genetically modified herpes simplex type 1 virus designed to directly destroy tumors and generate an anti-tumor immune response.

HealthDay News — Patients with osteoporosis who suffer a fragility fracture at age 80 years or older have better 5-year outcomes if they receive treatment for osteoporosis, according to a study ...

Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older ...

Overall, 12.4, 9.1, and 1.3% of urgent care visits led to antibiotic, glucocorticoid, and opioid prescription fills, respectively.

The Food and Drug Administration (FDA) has granted Priority Review to TAR-200 for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder ...

Astegolimab is a fully human anti-ST2 monoclonal antibody designed to bind to the ST2 receptor and block the IL-33 signalling pathway.

Opioids administered or prescribed in 35.0 and 32.5% of U.S. visits in 2016, respectively, compared with 24.5 and 13.5% in 2022.

Aldosterone suppression testing is suggested where screening results indicate an intermediate probability for lateralizing PA and patients wish to pursue eligibility for surgical therapy.

The third death occurred in an adult male with limb girdle muscular dystrophy who received a Sarepta AAVrh74 gene therapy product, SRP-9004, in a phase 4 clinical trial.

This analysis indicates that proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings," the researchers wrote.